Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 294

1.
2.

Survey of current treatment practices for venous thromboembolism in patients with cystic fibrosis.

Ratté MT, Jones AE, Witt DM, Young DC.

Pediatr Pulmonol. 2019 Sep 10. doi: 10.1002/ppul.24512. [Epub ahead of print]

PMID:
31502767
3.

Mycobacterium tuberculosis releases an antacid that remodels phagosomes.

Buter J, Cheng TY, Ghanem M, Grootemaat AE, Raman S, Feng X, Plantijn AR, Ennis T, Wang J, Cotton RN, Layre E, Ramnarine AK, Mayfield JA, Young DC, Jezek Martinot A, Siddiqi N, Wakabayashi S, Botella H, Calderon R, Murray M, Ehrt S, Snider BB, Reed MB, Oldfield E, Tan S, Rubin EJ, Behr MA, van der Wel NN, Minnaard AJ, Moody DB.

Nat Chem Biol. 2019 Sep;15(9):889-899. doi: 10.1038/s41589-019-0336-0. Epub 2019 Aug 19.

PMID:
31427817
4.

Driving complex flow waveforms with a linear voice coil actuator.

Young DC, Brehm JM, Scrimgeour J.

Biomicrofluidics. 2019 May 3;13(3):034101. doi: 10.1063/1.5086286. eCollection 2019 May.

PMID:
31110598
5.

Patients and families experience with pharmacist care at cystic fibrosis foundation accredited clinics.

Young DC, Autry E, Zobell JT, Kormelink L, Homa K, Sabadosa KA, Kanga J, Anstead M, Kuhn R.

Pediatr Pulmonol. 2019 Aug;54(8):1216-1224. doi: 10.1002/ppul.24348. Epub 2019 May 7.

PMID:
31066229
6.

An Evaluation of Vancomycin Area Under the Curve Estimation Methods for Children Treated for Acute Pulmonary Exacerbations of Cystic Fibrosis Due to Methicillin-Resistant Staphylococcus aureus.

Stockmann C, Olson J, Rashid J, Lubsch L, Young DC, Hersh AL, Frymoyer A, Ampofo K, Liu X, Wang Y, Sherwin CMT, Zobell JT.

J Clin Pharmacol. 2019 Feb;59(2):198-205. doi: 10.1002/jcph.1323. Epub 2018 Oct 29.

PMID:
30371946
7.

Population Pharmacokinetics of Amikacin in Adult Patients with Cystic Fibrosis.

Illamola SM, Huynh HQ, Liu X, Bhakta ZN, Sherwin CM, Liou TG, Carveth H, Young DC.

Antimicrob Agents Chemother. 2018 Sep 24;62(10). pii: e00877-18. doi: 10.1128/AAC.00877-18. Print 2018 Oct.

8.

Building Molecular Complexity from Quinizarin: Conjoined Coumarins and Coronene Analogs.

Węcławski MK, Deperasińska I, Banasiewicz M, Young DC, Leniak A, Gryko DT.

Chem Asian J. 2019 May 15;14(10):1763-1770. doi: 10.1002/asia.201800757. Epub 2018 Aug 27.

PMID:
30022613
9.

Optimizing likelihood models for particle trajectory segmentation in multi-state systems.

Young DC, Scrimgeour J.

Phys Biol. 2018 Jul 6;15(6):066003. doi: 10.1088/1478-3975/aacd5a.

PMID:
29916400
10.

Pharmacokinetics of Continuous Infusion Beta-lactams in the Treatment of Acute Pulmonary Exacerbations in Adult Patients With Cystic Fibrosis.

Hong LT, Liou TG, Deka R, King JB, Stevens V, Young DC.

Chest. 2018 Nov;154(5):1108-1114. doi: 10.1016/j.chest.2018.06.002. Epub 2018 Jun 13.

PMID:
29908155
11.

Multisystem Analysis of Mycobacterium tuberculosis Reveals Kinase-Dependent Remodeling of the Pathogen-Environment Interface.

Carette X, Platig J, Young DC, Helmel M, Young AT, Wang Z, Potluri LP, Moody CS, Zeng J, Prisic S, Paulson JN, Muntel J, Madduri AVR, Velarde J, Mayfield JA, Locher C, Wang T, Quackenbush J, Rhee KY, Moody DB, Steen H, Husson RN.

MBio. 2018 Mar 6;9(2). pii: e02333-17. doi: 10.1128/mBio.02333-17.

12.

Australian employee perceptions of an organizational-level intervention to reduce sitting.

Brakenridge CL, Healy GN, Hadgraft NT, Young DC, Fjeldsoe BS.

Health Promot Int. 2018 Dec 1;33(6):968-979. doi: 10.1093/heapro/dax037.

PMID:
28985286
13.

An Isoreticular Series of Zinc(II) Metal-Organic Frameworks Derived from Terpyridylcarboxylate Ligands.

Young DC, Yang H, Telfer SG, Kruger PE.

Inorg Chem. 2017 Oct 16;56(20):12224-12231. doi: 10.1021/acs.inorgchem.7b01632. Epub 2017 Sep 25.

PMID:
28945078
14.

Structural determination of lipid antigens captured at the CD1d-T-cell receptor interface.

Brennan PJ, Cheng TY, Pellicci DG, Watts GFM, Veerapen N, Young DC, Rossjohn J, Besra GS, Godfrey DI, Brenner MB, Moody DB.

Proc Natl Acad Sci U S A. 2017 Aug 1;114(31):8348-8353. doi: 10.1073/pnas.1705882114. Epub 2017 Jul 17.

15.

Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: II. Cephalosporins and penicillins update.

Zobell JT, Epps KL, Young DC.

Pediatr Pulmonol. 2017 Jul;52(7):863-865. doi: 10.1002/ppul.23713. Epub 2017 Jun 7. No abstract available.

PMID:
28590594
16.

Pyrazolo[4,3-h]quinoline Ligand-Based Iridium(III) Complexes for Electrochemiluminescence.

Hsu CW, Longhi E, Sinn S, Hawes CS, Young DC, Kruger PE, Cola L.

Chem Asian J. 2017 Jul 4;12(13):1649-1658. doi: 10.1002/asia.201700556. Epub 2017 Jun 6.

PMID:
28503856
17.

Total Synthesis of Mycobacterium tuberculosis Dideoxymycobactin-838 and Stereoisomers: Diverse CD1a-Restricted T Cells Display a Common Hierarchy of Lipopeptide Recognition.

Cheng JM, Liu L, Pellicci DG, Reddiex SJ, Cotton RN, Cheng TY, Young DC, Van Rhijn I, Moody DB, Rossjohn J, Fairlie DP, Godfrey DI, Williams SJ.

Chemistry. 2017 Jan 31;23(7):1694-1701. doi: 10.1002/chem.201605287. Epub 2017 Jan 18.

18.

Evaluating the effectiveness of organisational-level strategies with or without an activity tracker to reduce office workers' sitting time: a cluster-randomised trial.

Brakenridge CL, Fjeldsoe BS, Young DC, Winkler EA, Dunstan DW, Straker LM, Healy GN.

Int J Behav Nutr Phys Act. 2016 Nov 4;13(1):115.

19.

Stereoselective Synthesis of 1-Tuberculosinyl Adenosine; a Virulence Factor of Mycobacterium tuberculosis.

Buter J, Heijnen D, Wan IC, Bickelhaupt FM, Young DC, Otten E, Moody DB, Minnaard AJ.

J Org Chem. 2016 Aug 5;81(15):6686-96. doi: 10.1021/acs.joc.6b01332. Epub 2016 Jul 26.

20.

Organizational-Level Strategies With or Without an Activity Tracker to Reduce Office Workers' Sitting Time: Rationale and Study Design of a Pilot Cluster-Randomized Trial.

Brakenridge CL, Fjeldsoe BS, Young DC, Winkler EA, Dunstan DW, Straker LM, Brakenridge CJ, Healy GN.

JMIR Res Protoc. 2016 May 25;5(2):e73. doi: 10.2196/resprot.5438.

21.

Adherence to controller asthma medications: 6-month prevalence across a US community pharmacy chain.

Feehan M, Ranker L, Durante R, Cooper DK, Jones GJ, Young DC, Munger MA.

J Clin Pharm Ther. 2015 Oct;40(5):590-593. doi: 10.1111/jcpt.12316. Epub 2015 Aug 20.

PMID:
26291693
22.

NMR spectral properties of the tetramantanes - nanometer-sized diamondoids.

Balaban AT, Young DC, Plavec J, Pečnik K, Pompe M, Dahl JE, Carlson RM.

Magn Reson Chem. 2015 Dec;53(12):1003-18. doi: 10.1002/mrc.4289. Epub 2015 Aug 19.

PMID:
26286373
23.

On Intensive Late Holocene Iron Mining and Production in the Northern Congo Basin and the Environmental Consequences Associated with Metallurgy in Central Africa.

Lupo KD, Schmitt DN, Kiahtipes CA, Ndanga JP, Young DC, Simiti B.

PLoS One. 2015 Jul 10;10(7):e0132632. doi: 10.1371/journal.pone.0132632. eCollection 2015.

24.

Biomarkers for Tuberculosis Based on Secreted, Species-Specific, Bacterial Small Molecules.

Pan SJ, Tapley A, Adamson J, Little T, Urbanowski M, Cohen K, Pym A, Almeida D, Dorasamy A, Layre E, Young DC, Singh R, Patel VB, Wallengren K, Ndung'u T, Wilson D, Moody DB, Bishai W.

J Infect Dis. 2015 Dec 1;212(11):1827-34. doi: 10.1093/infdis/jiv312. Epub 2015 May 26.

25.

In vivo biosynthesis of terpene nucleosides provides unique chemical markers of Mycobacterium tuberculosis infection.

Young DC, Layre E, Pan SJ, Tapley A, Adamson J, Seshadri C, Wu Z, Buter J, Minnaard AJ, Coscolla M, Gagneux S, Copin R, Ernst JD, Bishai WR, Snider BB, Moody DB.

Chem Biol. 2015 Apr 23;22(4):516-526. doi: 10.1016/j.chembiol.2015.03.015.

26.

Lipidomic analysis links mycobactin synthase K to iron uptake and virulence in M. tuberculosis.

Madigan CA, Martinot AJ, Wei JR, Madduri A, Cheng TY, Young DC, Layre E, Murry JP, Rubin EJ, Moody DB.

PLoS Pathog. 2015 Mar 27;11(3):e1004792. doi: 10.1371/journal.ppat.1004792. eCollection 2015 Mar.

27.

Utilization of antibiotics for methicillin-resistant Staphylococcus aureus infection in cystic fibrosis.

Zobell JT, Epps KL, Young DC, Montague M, Olson J, Ampofo K, Chin MJ, Marshall BC, Dasenbrook E.

Pediatr Pulmonol. 2015 Jun;50(6):552-9. doi: 10.1002/ppul.23132. Epub 2015 Jan 5.

PMID:
25559432
28.

Quality of prenatal care questionnaire: instrument development and testing.

Heaman MI, Sword WA, Akhtar-Danesh N, Bradford A, Tough S, Janssen PA, Young DC, Kingston DA, Hutton EK, Helewa ME.

BMC Pregnancy Childbirth. 2014 Jun 3;14:188. doi: 10.1186/1471-2393-14-188.

29.

Molecular profiling of Mycobacterium tuberculosis identifies tuberculosinyl nucleoside products of the virulence-associated enzyme Rv3378c.

Layre E, Lee HJ, Young DC, Martinot AJ, Buter J, Minnaard AJ, Annand JW, Fortune SM, Snider BB, Matsunaga I, Rubin EJ, Alber T, Moody DB.

Proc Natl Acad Sci U S A. 2014 Feb 25;111(8):2978-83. doi: 10.1073/pnas.1315883111. Epub 2014 Feb 10.

30.

Pharmacokinetic and pharmacodynamic optimisation of intravenous tobramycin dosing among children with cystic fibrosis.

Sherwin CM, Zobell JT, Stockmann C, McCrory BE, Wisdom M, Young DC, Olson J, Ampofo K, Spigarelli MG.

J Pharmacokinet Pharmacodyn. 2014 Feb;41(1):71-9. doi: 10.1007/s10928-013-9348-7. Epub 2014 Jan 7.

PMID:
24395072
31.

Cutting Edge: CD1a tetramers and dextramers identify human lipopeptide-specific T cells ex vivo.

Kasmar AG, Van Rhijn I, Magalhaes KG, Young DC, Cheng TY, Turner MT, Schiefner A, Kalathur RC, Wilson IA, Bhati M, Gras S, Birkinshaw RW, Tan LL, Rossjohn J, Shires J, Jakobsen S, Altman JD, Moody DB.

J Immunol. 2013 Nov 1;191(9):4499-503. doi: 10.4049/jimmunol.1301660. Epub 2013 Oct 2.

32.

Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: V. Aminoglycosides.

Young DC, Zobell JT, Stockmann C, Waters CD, Ampofo K, Sherwin CM, Spigarelli MG.

Pediatr Pulmonol. 2013 Nov;48(11):1047-61. doi: 10.1002/ppul.22813. Epub 2013 Sep 2. Review.

PMID:
24000183
33.

Population pharmacokinetics of intermittent vancomycin in children with cystic fibrosis.

Stockmann C, Sherwin CM, Zobell JT, Lubsch L, Young DC, Olson J, Noyes BE, Ampofo K, Spigarelli MG.

Pharmacotherapy. 2013 Dec;33(12):1288-96. doi: 10.1002/phar.1320. Epub 2013 Jul 3.

PMID:
23824677
34.

Continuous infusion meropenem and ticarcillin-clavulanate in pediatric cystic fibrosis patients.

Zobell JT, Ferdinand C, Young DC.

Pediatr Pulmonol. 2014 Mar;49(3):302-6. doi: 10.1002/ppul.22820. Epub 2013 Jun 17.

PMID:
23775821
35.

The use of doripenem in pediatric cystic fibrosis patients in case of meropenem shortages.

Zobell JT, Kemper AL, Young DC.

Pediatr Pulmonol. 2014 Mar;49(3):E48-51. doi: 10.1002/ppul.22798. Epub 2013 May 9.

PMID:
23661625
36.

Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: VI. Executive summary.

Zobell JT, Young DC, Waters CD, Ampofo K, Stockmann C, Sherwin CM, Spigarelli MG.

Pediatr Pulmonol. 2013 Jun;48(6):525-37. doi: 10.1002/ppul.22757. Epub 2013 Jan 28. Review.

PMID:
23359557
37.

Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: II. cephalosporins and penicillins.

Zobell JT, Waters CD, Young DC, Stockmann C, Ampofo K, Sherwin CM, Spigarelli MG.

Pediatr Pulmonol. 2013 Feb;48(2):107-22. doi: 10.1002/ppul.22669. Epub 2012 Sep 4. Review.

PMID:
22949297
38.

Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: III. fluoroquinolones.

Stockmann C, Sherwin CM, Zobell JT, Young DC, Waters CD, Spigarelli MG, Ampofo K.

Pediatr Pulmonol. 2013 Mar;48(3):211-20. doi: 10.1002/ppul.22667. Epub 2012 Sep 4. Review.

PMID:
22949224
39.

Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: IV. colistimethate sodium.

Young DC, Zobell JT, Waters CD, Ampofo K, Stockmann C, Sherwin CM, Spigarelli MG.

Pediatr Pulmonol. 2013 Jan;48(1):1-7. doi: 10.1002/ppul.22664. Epub 2012 Sep 4.

PMID:
22949160
40.

Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: I. aztreonam and carbapenems.

Zobell JT, Young DC, Waters CD, Stockmann C, Ampofo K, Sherwin CM, Spigarelli MG.

Pediatr Pulmonol. 2012 Dec;47(12):1147-58. doi: 10.1002/ppul.22655. Epub 2012 Aug 21. Review.

PMID:
22911974
41.

Intermittent and extended-infusion beta-lactam utilization in cystic fibrosis.

Zobell JT, Young DC, Chatfield BA.

Pediatr Pulmonol. 2013 Jun;48(6):622-3. doi: 10.1002/ppul.22641. Epub 2012 Jul 23. No abstract available.

PMID:
22825925
42.

Neonatal outcome following failed Kiwi OmniCup vacuum extraction.

Edgar DC, Baskett TF, Young DC, O'Connell CM, Fanning CA.

J Obstet Gynaecol Can. 2012 Jul;34(7):620-5.

PMID:
22742480
43.

Ultralong C100 mycolic acids support the assignment of Segniliparus as a new bacterial genus.

Hong S, Cheng TY, Layre E, Sweet L, Young DC, Posey JE, Butler WR, Moody DB.

PLoS One. 2012;7(6):e39017. doi: 10.1371/journal.pone.0039017. Epub 2012 Jun 14.

44.

The diagnosis and management of ovarian hyperstimulation syndrome: No. 268, November 2011.

Joint Society of Obstetricians and Gynaecologists of Canada-Canadian Fertility and Andrology Society Clinical Practice Guidelines Committee, Shmorgun D, Claman P, Gysler M, Hemmings R, Cheung AP, Goodrow GJ, Hughes EG, Min JK, Roberts J, Senikas V, Wong BC, Young DC.

Int J Gynaecol Obstet. 2012 Mar;116(3):268-73.

PMID:
22416285
45.

Lipidomic discovery of deoxysiderophores reveals a revised mycobactin biosynthesis pathway in Mycobacterium tuberculosis.

Madigan CA, Cheng TY, Layre E, Young DC, McConnell MJ, Debono CA, Murry JP, Wei JR, Barry CE 3rd, Rodriguez GM, Matsunaga I, Rubin EJ, Moody DB.

Proc Natl Acad Sci U S A. 2012 Jan 24;109(4):1257-62. doi: 10.1073/pnas.1109958109. Epub 2012 Jan 9.

46.

A comparative lipidomics platform for chemotaxonomic analysis of Mycobacterium tuberculosis.

Layre E, Sweet L, Hong S, Madigan CA, Desjardins D, Young DC, Cheng TY, Annand JW, Kim K, Shamputa IC, McConnell MJ, Debono CA, Behar SM, Minnaard AJ, Murray M, Barry CE 3rd, Matsunaga I, Moody DB.

Chem Biol. 2011 Dec 23;18(12):1537-49. doi: 10.1016/j.chembiol.2011.10.013.

47.

Discovery of deoxyceramides and diacylglycerols as CD1b scaffold lipids among diverse groove-blocking lipids of the human CD1 system.

Huang S, Cheng TY, Young DC, Layre E, Madigan CA, Shires J, Cerundolo V, Altman JD, Moody DB.

Proc Natl Acad Sci U S A. 2011 Nov 29;108(48):19335-40. doi: 10.1073/pnas.1112969108. Epub 2011 Nov 15.

48.

The diagnosis and management of ovarian hyperstimulation syndrome.

Shmorgun D, Claman P; JOINT SOGC-CFAS CLINICAL PRACTICE GUIDELINES COMMITTEE.

J Obstet Gynaecol Can. 2011 Nov;33(11):1156-1162. doi: 10.1016/S1701-2163(16)35085-X.

PMID:
22082791
49.

Population pharmacokinetic and pharmacodynamic modeling of high-dose intermittent ticarcillin-clavulanate administration in pediatric cystic fibrosis patients.

Zobell JT, Stockmann C, Young DC, Cash J, McDowell BJ, Korgenski K, Sherwin CM, Spigarelli M, Chatfield BA, Ampofo K.

Clin Ther. 2011 Nov;33(11):1844-50. doi: 10.1016/j.clinthera.2011.09.010. Epub 2011 Oct 21.

PMID:
22018680
50.

Antigen-directed cancer surgery for primary colorectal cancer: 15-year survival analysis.

Povoski SP, Hatzaras IS, Mojzisik CM, Arnold MW, Hinkle GH, Hitchcock CL, Young DC, Martin EW Jr.

Ann Surg Oncol. 2012 Jan;19(1):131-8. doi: 10.1245/s10434-011-1880-3. Epub 2011 Jul 6.

PMID:
21732140

Supplemental Content

Loading ...
Support Center